+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
Dexamethasone (CAS 50-02-2) Global Market Research Report 2024 - Product Thumbnail Image

Dexamethasone (CAS 50-02-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Desipramine (CAS 50-47-5) Global Market Research Report 2024 - Product Thumbnail Image

Desipramine (CAS 50-47-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Ciclazindol (CAS 37751-39-6) Global Market Research Report 2024 - Product Thumbnail Image

Ciclazindol (CAS 37751-39-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Casopitant (CAS 414910-27-3) Global Market Research Report 2024 - Product Thumbnail Image

Casopitant (CAS 414910-27-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more